Showing results (281-290 of 1,013) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|July 26, 2023
Clinically Defined Mutations in MEN1 Alter Its Tumor-suppressive Function Through Increased Menin TurnoverSuzann Duan, Sulaiman Sheriff, Uloma B Elvis-Offiah, et al.Cancer Research Communications|December 27, 2021
Sex- and mutation-specific p53 gain-of-function activity in gliomagenesisNathan C Rockwell, Wei Yang, Nicole M Warrington, et al.Cancer Research Communications|October 28, 2022
A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 womenXiaoliang Wang, Hongjie Chen, Pooja Middha Kapoor, et al.Cancer Research Communications|October 28, 2022
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast CancerMargaret L Axelrod, Yu Wang, Yaomin Xu, et al.Cancer Research Communications|August 8, 2022
A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and AngiogenesisNamrata Bora-Singhal, Biswarup Saha, Durairaj Mohankumar, et al.Cancer Research Communications|August 1, 2022
World Trade Center dust exposure promotes cancer in PTEN-deficient mouse prostatesLin Wang, Yitian Xu, Licheng Zhang, et al.Cancer Research Communications|November 25, 2022
Dietary Nonstarch Polysaccharide Intake and Risk of Colorectal Cancer: Findings from the Singapore Chinese Health StudyYi-Chuan Yu, Pedram Paragomi, Aizhen Jin, et al.Cancer Research Communications|June 29, 2022
Combinatorial Natural Killer Cell-based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem CellsAustin T K Hoke, Michelle R Padget, Kellsye P Fabian, et al.Cancer Research Communications|January 16, 2023
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patientHenkel Valentine, William Aiken, Belinda Morrison, et al.Cancer Research Communications|May 25, 2022
In silico epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccinesC Alston James, Peter Ronning, Darren Cullinan, et al.Pageof 102